These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27324602)

  • 1. Tocilizumab-induced hypofibrinogenemia: A report of 7 cases.
    Martis N; Chirio D; Queyrel-Moranne V; Zenut MC; Rocher F; Fuzibet JG
    Joint Bone Spine; 2017 May; 84(3):369-370. PubMed ID: 27324602
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review.
    Üsküdar Cansu D; Demirtaş E; Andiç N; Üsküdar Teke H; Korkmaz C
    Rheumatol Int; 2019 Apr; 39(4):743-750. PubMed ID: 30874871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study.
    Tauber M; Buche S; Reygagne P; Berthelot JM; Aubin F; Ghislain PD; Cohen JD; Coquerelle P; Goujon E; Jullien D; Brixi H; Jeudy G; Guennoc X; Martin A; Brénaut E; Hoppé E; Bertolotti A; Bardin T; Delaporte E; Allez M; Bachelez H; Seneschal J; Viguier M; ; ;
    J Am Acad Dermatol; 2014 Jun; 70(6):1146-9. PubMed ID: 24831323
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Sciumè M; Fracchiolla NS; Cortelezzi A
    Leuk Lymphoma; 2018 Oct; 59(10):2516-2517. PubMed ID: 29384412
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective treatment of idiopathic chronic cold urticaria with omalizumab: report of 3 cases.
    Le Moing A; Bécourt C; Pape E; Dejobert Y; Delaporte E; Staumont-Sallé D
    J Am Acad Dermatol; 2013 Aug; 69(2):e99-101. PubMed ID: 23866899
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study.
    Dogra S; D S K; Budamakuntla L; Srinivas CR; Khopkar U; Gupta S; Shetty N; Pratap DV; Gopal MG; Rao TN; Garg V; Sumathy TK; Saraswat A; Bhat R; Kura M; Pandey N; Shah R; Sai Krishna K; Padmaja D; Manmohan G; M S R; Barve A; Montero E
    J Am Acad Dermatol; 2015 Aug; 73(2):331-3.e1. PubMed ID: 26183983
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained tocilizumab-induced hypofibrinogenemia and thrombocytopenia. Comment on: "Tocilizumab-induced hypofibrinogenemia: A report of 7 cases" by Martis et al., Joint Bone Spine 2016, doi: 10.1016/j.jbspin.2016.04.008.
    Vitiello G; Orsi Battaglini C; Radice A; Carli G; Micheli S; Cammelli D
    Joint Bone Spine; 2017 Oct; 84(5):649-650. PubMed ID: 28363823
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic effect of tocilizumab on two patients with polymyositis.
    Narazaki M; Hagihara K; Shima Y; Ogata A; Kishimoto T; Tanaka T
    Rheumatology (Oxford); 2011 Jul; 50(7):1344-6. PubMed ID: 21515628
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study.
    Balsa A; Tovar Beltrán JV; Cáliz Cáliz R; Mateo Bernardo I; García-Vicuña R; Rodríguez-Gómez M; Belmonte Serrano MA; Marras C; Loza Cortina E; Pérez-Pampin E; Vila V
    Rheumatol Int; 2015 Sep; 35(9):1525-34. PubMed ID: 25773655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable Responses to Tocilizumab in Four Patients with Schnitzler Syndrome.
    Claus J; Vanderschueren S
    J Clin Immunol; 2019 May; 39(4):370-372. PubMed ID: 31111419
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypofibrinogenemia due to L-asparaginase: studies of fibrinogen survival using autologous 131-I-fibrinogen.
    Bettigole RE; Himelstein ES; Oettgen HF; Clifford GO
    Blood; 1970 Feb; 35(2):195-200. PubMed ID: 4905780
    [No Abstract]   [Full Text] [Related]  

  • 12. Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
    Yokota S; Imagawa T; Mori M; Miyamae T; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
    J Rheumatol; 2014 Apr; 41(4):759-67. PubMed ID: 24634205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypofibrinogenemia caused by long-term administration of hemocoagulase: three cases report and literature review].
    Wang Z; Li J; Cao L; Yu Z; Bai X; Ruan C
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):50-2. PubMed ID: 24602733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofibrinogenemia induced by high-dose tigecycline-case report and review of literature.
    Fan Q; Huang W; Weng Y; Xie X; Shi Z
    Medicine (Baltimore); 2020 Oct; 99(43):e22638. PubMed ID: 33120753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE.
    Terreaux W; Masson C; Eschard JP; Bardin T; Constantin A; Le Dantec L; Marcelli C; Perdriger A; Scotto Di Fazano C; Wendling D; Sibilia J; Morel J; Salmon JH
    Joint Bone Spine; 2018 Jan; 85(1):53-57. PubMed ID: 28115268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of two cases of tocilizumab induced recurrent meningitis or meningoencephalitis.
    Richebé P; Bailly F; Mariani LL; Pena PS; Pedespan JM; Fautrel B
    Joint Bone Spine; 2018 Oct; 85(5):643-644. PubMed ID: 29366968
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies.
    Georgakopoulos JR; Phung M; Ighani A; Yeung J
    J Am Acad Dermatol; 2018 Jul; 79(1):155-157. PubMed ID: 29307635
    [No Abstract]   [Full Text] [Related]  

  • 18. Tigecycline-associated hypofibrinogenemia in a real-world setting.
    Campany-Herrero D; Larrosa-Garcia M; Lalueza-Broto P; Rivera-Sánchez L; Espinosa-Pereiro J; Mestre-Torres J; Pigrau-Serrallach C
    Int J Clin Pharm; 2020 Aug; 42(4):1184-1189. PubMed ID: 32504166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.
    Silpa-Archa S; Oray M; Preble JM; Foster CS
    Acta Ophthalmol; 2016 Sep; 94(6):e400-6. PubMed ID: 27010181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
    Devauchelle-Pensec V; Berthelot JM; Cornec D; Renaudineau Y; Marhadour T; Jousse-Joulin S; Querellou S; Garrigues F; De Bandt M; Gouillou M; Saraux A
    Ann Rheum Dis; 2016 Aug; 75(8):1506-10. PubMed ID: 26929219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.